Pegylated interferon alfa

This page covers all Pegylated interferon alfa drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Interferon-alpha receptor (IFNAR).

Targets

Interferon-alpha receptor (IFNAR)

Marketed (1)

• PEG -Intron · Beth Israel Deaconess Medical Center · Immunology / Virology
  PEG-Intron is a pegylated interferon alfa-2b that enhances and prolongs the antiviral immune response by binding to interferon receptors on immune cells.

Phase 3 pipeline (1)

• Peginterferon alfa-2b (PEG) · Merck Sharp & Dohme LLC · Immunology, Virology, Oncology
  Peginterferon alfa-2b is a pegylated form of interferon alfa-2b that enhances and prolongs immune activation by binding to interferon-alpha receptors on immune cells.